Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-04

Clinical Trial Update: Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology [Phase 4]

View source ↗

Summary

Phase 4 trial update shows completion of study evaluating the effects of Tracleer (bosentan) on pulmonary arterial hypertension related to Eisenmenger physiolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRACLEER (bosentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension Related to Eisenmenger Physiology | Phase 4 | Status: COMPLETED